// App-Quantinova.ai

e16103 : Incidence of brain metastases in metastatic renal cell carcinoma in the era of targeted therapies.

Researchers

Presenter

  • I. Alex Bowman

Principal Investigators

  • Tri Le

  • Alana Christie

  • James Brugarolas

Medical Centers

  • Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Metastatic Renal Cell Cancer

  • Brain metastasis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final